Value Of Small Biotech Model In Big Pharma Is Unproven – Former GSK Execs
This article was originally published in The Pink Sheet Daily
Executive Summary
GSK’s formation of the Centers of Excellence in Drug Discovery is an example of big pharma “pushing back” on inherent inefficiencies, but the “jury is still out” on large pharmaceutical companies imitating the biotech business model, former execs O’Bryan-Tear and Sorensen say.